首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

导出 OA

翻译打印收藏纠错

第一作者： Shiori,Saito

第一单位： Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.

作者： Shiori,Saito ^[1] ; Jiro,Kikuchi ^[1] ; Daisuke,Koyama ^[1] ; Shin,Sato ^[2] ; Hiroo,Koyama ^[3] ; Naoki,Osada ^[1] ; Yoshiaki,Kuroda ^[1] ; Koshi,Akahane ^[4] ; Takeshi,Inukai ^[4] ; Takashi,Umehara ^[2] ; Yusuke,Furukawa ^[5]

作者单位： Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. ^[1] Epigenetics Drug Discovery Unit, RIKEN Center for Life Science Technologies, Yokohama, Kanagawa, Japan. ^[2] Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan. ^[3] Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan. ^[4] Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. furuyu@jichi.ac.jp. ^[5]